DMK PHARMACEUTICALS Corp reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
DMK PHARMACEUTICALS Corp has filed 1,210 SEC EDGAR filings since 13 Feb 1996

SEC filing history

Showing 101-125 of 775 matching filings.

Per page
25
Current page
5
8-K File 001-36242

CURRENT REPORT

Filing date
12 Sep 2022
Reporting date
08 Sep 2022
Next action
Verify source filing
S-3 File 333-267365

REGISTRATION STATEMENT

Filing date
09 Sep 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36242

DEFINITIVE ADDITIONAL MATERIALS

Filing date
18 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
17 Aug 2022
Reporting date
12 Aug 2022
Next action
Verify source filing
DEFA14A File 001-36242

DEFINITIVE ADDITIONAL MATERIALS

Filing date
15 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
10 Aug 2022
Reporting date
10 Aug 2022
Next action
Verify source filing
10-Q File 001-36242

QUARTERLY REPORT

Filing date
10 Aug 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
DEFA14A File 001-36242

ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS

Filing date
05 Aug 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
01 Aug 2022
Reporting date
29 Jul 2022
Next action
Verify source filing
DEFA14A File 001-36242

DEFINITIVE ADDITIONAL MATERIALS

Filing date
29 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
29 Jul 2022
Reporting date
29 Jul 2022
Next action
Verify source filing
DEFA14A File 001-36242

DEFINITIVE ADDITIONAL MATERIALS

Filing date
21 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36242

DEFINITIVE PROXY STATEMENT

Filing date
07 Jul 2022
Reporting date
05 Aug 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-451511

D filing

Filing date
07 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36242

ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS

Filing date
06 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
06 Jul 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
24 Jun 2022
Reporting date
22 Jun 2022
Next action
Verify source filing
PRE 14A File 001-36242

PRELIMINARY PROXY STATEMENT

Filing date
17 Jun 2022
Reporting date
29 Jul 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
17 Jun 2022
Reporting date
14 Jun 2022
Next action
Verify source filing
4

4 filing

Filing date
27 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
26 May 2022
Reporting date
24 May 2022
Next action
Verify source filing
3

3 filing

Filing date
26 May 2022
Reporting date
24 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 May 2022
Reporting date
24 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
19 May 2022
Reporting date
17 May 2022
Next action
Verify source filing
8-K File 001-36242

CURRENT REPORT

Filing date
16 May 2022
Reporting date
16 May 2022
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .